trial · primary record
GEN1106
Solid Tumors
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 103 |
| Primary completion | 2029-06-25 |
| Primary endpoint | Part 1 Dose Escalation: Number of Participants with Dose Limiting Toxicities (DLTs) |
| Registry ID | NCT07416123 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:58.914Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07416123
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.